ARTL
Price
$5.51
Change
-$0.05 (-0.90%)
Updated
Sep 26 closing price
Capitalization
10.81M
IGC
Price
$0.40
Change
+$0.01 (+2.56%)
Updated
Sep 26 closing price
Capitalization
36.57M
46 days until earnings call
Interact to see
Advertisement

ARTL vs IGC

Header iconARTL vs IGC Comparison
Open Charts ARTL vs IGCBanner chart's image
Artelo Biosciences
Price$5.51
Change-$0.05 (-0.90%)
Volume$15.03K
Capitalization10.81M
IGC Pharma
Price$0.40
Change+$0.01 (+2.56%)
Volume$304.86K
Capitalization36.57M
ARTL vs IGC Comparison Chart in %
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTL vs. IGC commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and IGC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ARTL: $5.51 vs. IGC: $0.40)
Brand notoriety: ARTL and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 12% vs. IGC: 32%
Market capitalization -- ARTL: $10.81M vs. IGC: $36.57M
ARTL [@Biotechnology] is valued at $10.81M. IGC’s [@Biotechnology] market capitalization is $36.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 0 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • ARTL’s FA Score: 0 green, 5 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, IGC is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 5 TA indicator(s) are bullish while IGC’s TA Score has 3 bullish TA indicator(s).

  • ARTL’s TA Score: 5 bullish, 3 bearish.
  • IGC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARTL is a better buy in the short-term than IGC.

Price Growth

ARTL (@Biotechnology) experienced а -1.96% price change this week, while IGC (@Biotechnology) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

IGC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGC($36.6M) has a higher market cap than ARTL($10.8M). IGC YTD gains are higher at: 18.363 vs. ARTL (-13.365). IGC has higher annual earnings (EBITDA): -6.36M vs. ARTL (-10.71M). ARTL has more cash in the bank: 2.07M vs. IGC (454K). IGC has less debt than ARTL: IGC (202K) vs ARTL (878K). IGC has higher revenues than ARTL: IGC (1.33M) vs ARTL (0).
ARTLIGCARTL / IGC
Capitalization10.8M36.6M30%
EBITDA-10.71M-6.36M168%
Gain YTD-13.36518.363-73%
P/E RatioN/AN/A-
Revenue01.33M-
Total Cash2.07M454K455%
Total Debt878K202K435%
FUNDAMENTALS RATINGS
ARTL vs IGC: Fundamental Ratings
ARTL
IGC
OUTLOOK RATING
1..100
1083
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9145
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IGC's Valuation (45) in the Biotechnology industry is in the same range as ARTL (54) in the null industry. This means that IGC’s stock grew similarly to ARTL’s over the last 12 months.

IGC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that IGC’s stock grew similarly to ARTL’s over the last 12 months.

IGC's SMR Rating (99) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that IGC’s stock grew similarly to ARTL’s over the last 12 months.

IGC's Price Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for ARTL (91) in the null industry. This means that IGC’s stock grew somewhat faster than ARTL’s over the last 12 months.

IGC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that IGC’s stock grew similarly to ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLIGC
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLKN17.980.40
+2.28%
MillerKnoll
EGO28.850.30
+1.05%
Eldorado Gold Corp
DASH262.470.39
+0.15%
DoorDash
AVBH25.20-0.17
-0.67%
Avidbank Holdings Inc
MSW2.78-0.08
-2.80%
Ming Shing Group Holdings Ltd

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with MTNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-0.90%
MTNB - ARTL
37%
Loosely correlated
+1.06%
NEVPF - ARTL
35%
Loosely correlated
N/A
PALI - ARTL
34%
Loosely correlated
+16.20%
IGC - ARTL
30%
Poorly correlated
+1.77%
PHIO - ARTL
28%
Poorly correlated
+1.36%
More

IGC and

Correlation & Price change

A.I.dvisor tells us that IGC and ARTL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGC and ARTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
+1.77%
ARTL - IGC
30%
Poorly correlated
-0.90%
MRNA - IGC
29%
Poorly correlated
-0.49%
KZR - IGC
29%
Poorly correlated
-2.67%
KPTI - IGC
27%
Poorly correlated
-1.65%
LRMR - IGC
26%
Poorly correlated
+4.84%
More